In a large series of MGUS patients followed prospectively, transformation to multiple myeloma or other hematological malignancy, although present, was at a rate considerably lower than expected, based upon reports from retrospective series. Nevertheless, overall survival for MGUS patients was significantly less than that for the general population. Go Back
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.